|
 |
Global biochip markets to increase to $6 billion by 2014
 |
|
| According to a new technical market research report from BCC Research, the global market value for biochip products is an estimated $2.6 billion in 2009, but is expected to increase to nearly $6 billion in 2014, for a 5-year CAGR of 17.7% |
|
 |
|
|
| |
| Global vaccine market to see growth of 13% during 2009-12
|
|
| Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent 2 largest |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Biotech crops poised for second wave of growth
|
|
| Biotech crops, on the heels of a robust 2008 and bolstered by increased political will to meet food demands, are poised for a second wave of strong adoption, that will drive sustained global growth |
|
|
|
|
| |
|
|
| |
| Trials show nutritional supplement lowers metabolic markers
|
|
| Clinical trial show that a structured and integrated intervention program, including nutritional supplement Glucerna SR, dietary and nutrition modification, blood glucose monitoring and diabetes education, significantly lowers key metabolic markers |
|
|
|
|
| |
| SGX unveils new rules
|
|
| The biomedical sciences industry in Singapore has grown tremendously fast with the biomedical manufacturing output expanding fourfold from $4.64 billion (S$6.3 billion) to $17.67 billion (S$24 billion) in 2007 at a Compounded Annual Growth Rate |
|
|
|
|
| More |
